Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the initiation of a Phase 2 trial for its investigational drug bosakitug (ATI-045), targeting moderate-to-severe atopic dermatitis (AD). This randomized, …
Aclaris Therapeutics Launches Phase 2 Trial for Promising Atopic Dermatitis Treatment Read More
PHILADELPHIA, PA — The results of a new study suggest patients with chronic pain are turning to medical cannabis to find relief and are also breaking free from traditional painkillers …
Medical Cannabis Reduces Pain and Opioid Pill Use, Preserves Cognition, Study Reveals Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) presented significant clinical findings at the 2025 American Urological Association (AUA) Annual Meeting in Las Vegas. The data from two randomized controlled trials …
Teleflex Highlights UroLift™ System’s Clinical Advantages at 2025 AUA Meeting Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) unveiled significant progress in its efforts to combat neurodegenerative diseases with updates on its pivotal Phase 3 clinical trial and solid financial …
Annovis Bio Advances Phase 3 Alzheimer’s Trial Amid Steady Financial Progress Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced the publication of a new retrospective study linking the use of its Titan SGS™ Stapler with significantly reduced rates of post-operative gastroesophageal …
Study Highlights Reduced Post-Operative GERD Rates Tied to Titan SGS Stapler in Sleeve Gastrectomy Read More
SAN DIEGO, CA / TOKYO, Japan / MALVERN, PA — Fujirebio Holdings Inc., its subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. have announced the successful completion of a prospective …
Fujirebio and AriBio Achieve Milestone in Biomarker Advancement for Alzheimer’s Disease Read More
WAYNE, PA — Cagent Vascular has announced the enrollment of the first patient in its groundbreaking Serranator vs. POBA OCT Study. This innovative clinical trial aims to evaluate the benefits …
Cagent Vascular Launches Landmark Study on Serration Angioplasty Technology Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the presentation of its investigational therapy QTORIN™ rapamycin 3.9% anhydrous gel for microcystic lymphatic malformations (microcystic LMs) at the 15th World …
Palvella Therapeutics Showcases Progress on QTORIN Rapamycin Gel for Rare Genetic Disorder Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has shared promising preliminary results from its Ringer™ PBC IDE study, featured in a presentation at the CTO Plus Conference in New York. The …
Teleflex Reports Promising Preliminary Results for Ringer PBC Study Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage biopharmaceutical company, is set to showcase significant advancements in its treatments for Alzheimer’s disease (AD) and Parkinson’s disease (PD) at the …
Annovis Bio to Present Promising Data on Buntanetap at AD/PD™ 2025 Read More